Ahmed, N, Wahlgren, N, Brainin, M, Castillo, J, Ford, GA, Kaste, M, et al., for the SITS Investigators. (2009). Relationship of blood pressure, antihypertensive therapy, and outcome in ischaemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke, 40, 2442–9.CrossRefGoogle ScholarPubMed

Al-Hazmi, H. (2015). Role of duration of catheterization and length of hospital stay on the rate of catheter-related hospital-acquired urinary tract infections. Res Rep Urol, 7, 41–7Google ScholarPubMed

Ali, L, Saver, JL. (2007). The ischemic stroke patient who worsens: new assessment and management approaches. Rev Neurol Dis, 4, 85–91.Google Scholar

Anderson, CS, Arima, H, Lavados, P, Billot, L, Hackett, ML, Olavarria, VV, et al. (2017). Cluster-randomized, crossover trial of head positioning in acute stroke. New Engl J Med, 376, 2437–47.CrossRefGoogle ScholarPubMed

Aries, MJ, Elting, JW, Stewart, R, De Keyser, J, Kremer, B, Vroomen, P. (2013). Cerebral blood flow velocity changes during upright positioning in bed after acute stroke: an observational study. BMJ Open, 3:e002960. doi:10.1136/bmjopen-2013-002960.CrossRefGoogle ScholarPubMed

Aslanyan, S, Weir, CJ, Diener, HC, Kaste, M, Lees, KR; GAIN International Steering Committee and Investigators. (2004). Pneumonia and urinary tract infection after acute ischemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol, 11, 49–53.CrossRefGoogle Scholar

Bath, PMW, Krishnan, K. (2014). Interventions for deliberately altering blood pressure in acute stroke (Review). Cochrane Database Syst Rev, 10, CD000039. doi:10.1002/14651858.CD000039.pub3.Google Scholar

Bath, PM, Lee, HS, Everton, LF. (2018). Swallowing therapy for dysphagia in acute and subacute stroke. Cochrane Database Syst Rev, 10. CD000323. doi:10.1002/14651858.CD000323.pub3.Google ScholarPubMed

Bellolio, MF, Gilmore, RM, Ganti, L. (2014). Insulin for glycaemic control in acute ischaemic stroke. Cochrane Database Syst Rev, 1, CD005346. doi:10.1002/14651858.CD005346.pub4.Google Scholar

Bennett, MH, Weibel, S, Wasiak, J, Schnabel, A, French, C, Kranke, P. (2014). Hyperbaric oxygen therapy for acute ischaemic stroke. Cochrane Database Syst Rev, 11, CD004954. doi:10.1002/14651858.CD004954.pub3.Google Scholar

Bruno, A, Durkalski, VL, Hall, CE, Juneja R, Barsan WG, Janis S, et al., on behalf of the SHINE Investigators. (2014). The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial protocol; a randomized, blinded, efficacy trial of standard versus intensive hyperglycemia management in acute stroke. Int J Stroke, 9, 246–51.Google Scholar

Capes, SE, Hunt, D, Malmberg, K, Pathak, P, Gerstein, HC. (2001). Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke, 32, 2426–32.Google Scholar

Castillo, J, Davalos, A, Marrugat, J, Noya, M. (1998). Timing for fever-related brain damage in acute ischemic stroke. Stroke, 29, 2455–60.CrossRefGoogle ScholarPubMed

Castillo, J, Leira, R, García, MM, Serena, J, Blanco, M, Dávalos, A. (2004). Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke, 35, 520–6.Google Scholar

Chen, PC, Chuang, CH, Leong, CP, Guo, SE, Hsin, YJ. (2016). Systematic review and meta-analysis of the diagnostic accuracy of the water swallow test for screening aspiration in stroke patients. J Adv Nurs, 72, 2575–86.Google Scholar

Chung, HW, Kim, SK, Kim, SJ, Lee, MJ, Hwang, J, Seo, WK, et al. (2018). Therapeutic induced hypertension in acute stroke patients with non-cardioembolic stroke: a multicenter, randomized controlled trial. Eur Stroke J, 3, 7.Google Scholar

CLOTS Trials Collaboration. (2009). Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicenter, randomized controlled trial. Lancet, 373, 1958–65.Google Scholar

CLOTS Trials Collaboration. (2013). Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicenter randomized controlled trial. Lancet, 382, 516–24.Google Scholar

Cryer, PE, Davis, SN, Shamoon, H. (2003). Hypoglycemia in diabetes. Diabetes Care, 26, 1902–12.Google Scholar

Daniels, SK, Ballo, LA, Mahoney, M-C, Foundas, AL. (2000). Clinical predictors of dysphagia and aspiration risk: outcome measures in acute stroke patients. Arch Phys Med Rehabil, 81, 1030–3.Google Scholar

den Hertog, HM, van der Worp, HB, Tseng, MC, Dippel, DWJ. (2009). Cooling therapy for acute stroke. Cochrane Database Syst Rev, 1, CD001247. doi:10.1002/14651858.CD001247.pub2.CrossRefGoogle ScholarPubMed

Dennis, M, Caso, V, Kappelle, LJ, Pavlovic, A, Sandercock, P, for the European Stroke Organisation. (2016). European Stroke Organisation (ESO) guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischaemic stroke. Eur Stroke J, 1, 6–19.CrossRefGoogle ScholarPubMed

de Ridder, IR, den Hertog, HM, van Gemert, HM, Schreuder, AH, Ruitenberg, A, Maasland, EL, et al; Trial Organization. (2017). PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): results of a randomized, double-blind placebo-controlled clinical trial. Stroke, 48, 977–82.Google Scholar

Ding, J, Zhou, D, Sui, M, Meng, R, Chandra, A, Han, J, et al. (2018). The effect of normobaric oxygen in patients with acute stroke: a systematic review and meta-analysis. Neurol Res, 40, 433–44. doi:10.1080/01616412.2018.1454091.CrossRefGoogle ScholarPubMed

Dirnagl, U, Pulsinelli, W. (1990). Autoregulation of cerebral blood flow in experimental focal brain ischemia. J Cereb Blood Flow Metab, 10, 327–36.Google Scholar

Donnelly, J, Budohoski, KP, Smielewski, P, Czosnyka, M. (2016). Regulation of the cerebral circulation: bedside assessment and clinical implications. Crit Care, 20, 129.Google Scholar

Douds, GL, Hellkamp, AS, DaiWai, M, Olson, DM, Fonarow, GC, Smith, EE, et al. (2014). Venous thromboembolism in the Get with the Guidelines-Stroke acute ischemic stroke population: incidence and patterns of prophylaxis. J Stroke Cerebrovasc, 23, 123–9.Google Scholar

Durduran, T, Zhou, C, Edlow, BL, Yu, G, Choe, R, Kim, MN, et al. (2009). Transcranial optical monitoring of cerebrovascular hemodynamics in acute stroke patients. Opt Express, 17, 3884–902.Google Scholar

Dziewas, R, Stellato, R, van der Tweel, I, Walther, E, Werner, CJ, Braun, T, et al. (2018). Pharyngeal electrical stimulation for early decannulation in tracheotomised patients with neurogenic dysphagia after stroke (PHAST-TRAC): a prospective, single-blinded, randomised trial. Lancet Neurol, 17, 849–59.Google Scholar

Edmiaston, J, Connor, LT, Steger-May, K, Ford, AL. (2014). A simple bedside dysphagia screen, validated against videofluoroscopy, detects dysphagia and aspiration with high sensitivity. J Stroke Cerobrovasc Dis, 23, 712–16.Google ScholarPubMed

Famakin, BM. (2014). The immune response to acute focal cerebral ischemia and associated post-stroke immunodepression: a focused review. Aging Dis, 5, 307–26.Google Scholar

Favilla, CG, Mesquita, RC, Mullen, M, Durduran, T, Lu, X, Kim, MN, et al. (2014). Optical bedside monitoring of cerebral blood flow in acute ischemic stroke patients during head-of-bed manipulation. Stroke, 45, 1269–74.Google Scholar

FOOD Trial Collaboration. (2003). Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the FOOD trial. Stroke, 34, 1450–6.Google Scholar

FOOD Trial Collaboration. (2005a). Routine oral nutritional supplementation for stroke patients in hospital (FOOD): a multi centre randomized controlled trial. Lancet, 365, 755–63.Google Scholar

FOOD Trial Collaboration. (2005b). Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomized controlled trial. Lancet, 365, 764–72.Google Scholar

Galovic, M, Leisi, N, Müller, M. (2013). Lesion location predicts transient and extended risk of aspiration after supratentorial ischemic stroke. Stroke, 44, 2760–7.Google Scholar

Grau, AJ, Buggle, F, Schnitzler, P, Spiel, M, Lichy, C, Hacke, W. (1999). Fever and infection early after ischemic stroke. J Neurol Sci, 171, 115–20.Google Scholar

Gray, CS, Hildreth, AJ, Sandercock, PA, O’Connell, JE, Johnston, DE, Cartlidge, NE, et al.; GIST Trialists Collaboration. (2007). Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol, 6, 397–406.Google Scholar

Hansford, BG, Albert, D, Yang, E. (2013). Classic neuroimaging findings of nonketotic hyperglycemia on computed tomography and magnetic resonance imaging with absence of typical movement disorder symptoms (hemichorea-hemiballism). Radiology Case, 7, 1–9.Google Scholar

Hillis, AE, Ulatowski, JA, Barker, PB, Torbey, M, Ziai, W, Beauchamp, NJ, et al. (2003). A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis, 16, 236–46.Google Scholar

Hinchey, JA, Shephard, T, Furie, K, Smith, D, Wang, D, Tonn, S, for the Stroke Practice Improvement Network Investigators. (2005). Formal dysphagia screening protocols prevent pneumonia. Stroke, 36, 1972–6.Google Scholar

Huang, L-C, Ruge, D, Tsai, C-L, Wu, MN, Hsu, CY, Lai, CL, et al. (2014). Isolated aphasic status epilepticus as initial presentation of nonketotic hyperglycemia. Clin EEG Neurosci, 45, 126–8.Google Scholar

Indredavik, B, Rohweder, G, Naalsund, E, Lydersen, S. (2008). Medical complications in a comprehensive stroke unit and an Early Supported Discharge Service. Stroke, 39, 414–20.Google Scholar

International Stroke Trial Collaborative Group. (1997). The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet, 349, 1569–81.Google Scholar

Johnston, KC, Bruno, A, Paulis, Q, Hall, CE, Barrett, KM, Barsan, W, et al. (2019). Intensive versus standard treatment of hyperglycemia and functional outcomes in patients with acute ischemic stroke: the SHINE randomized clinical trial. JAMA, 322, 326–35.CrossRefGoogle Scholar

Joundi, RA, Martino, R, Saposnik, G, Giannakeas, V, Fang, J, Kapral, MK. (2017). Predictors of outcomes of dysphagia screening after acute ischemic stroke. Stroke, 48:900–6.Google Scholar

Kakkos, SK, Caprini, JA, Geroulakos, G, Nicolaides, AN, Stansby, G, Reddy, DJ, et al. (2016). Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism. Cochrane Database Syst Rev, 9. CD005258.DOI:10.1002/14651858.CD005258.pub3.Google Scholar

Kalita, J, Singh, RK, Misra, UK. (2017). Cerebral salt wasting is the most common cause of hyponatremia in stroke. J Stroke Cerebrovasc Dis, 26, 1026–32.Google Scholar

Karepov, VG, Gur, AY, Bova, I, Aronovich, BD, Bornstein, NM. (2006). Stroke-in-evolution: infarct-inherent mechanisms versus systemic causes. Cerebrovasc Dis, 21, 42–6.Google Scholar

Khan, MT, Ikram, A, Saeed, O, Afridi, T, Sila, CA, Smith, MS, et al. (2017). Deep vein thrombosis in acute stroke – a systemic review of the literature. Cureus, 9, e1982. doi:10.7759/cureus.1982.Google Scholar

Kim, SH, Saver, JL. (2015). Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity. Stroke, 46, 132–6.Google Scholar

Kim, TJ, Ko, SB, Jeong, HG, Kim, CK, Kim, Y, Nam, K, et al. (2017). Nocturnal desaturation is associated with neurological deterioration following ischemic stroke: a retrospective observational study. J Clin Sleep Med, 13, 1273–9.Google Scholar

Lee, M, Ovbiagele, B, Hong, KS, Wu, YL, Lee, JE, Rao, NM, et al. (2015). Effect of blood pressure lowering in early ischemic stroke: meta-analysis. Stroke, 46, 1883–9.Google Scholar

Lin, J, Weng, Y, Li, M, Mo, Y, Zhao, J. (2018). Hydration prevents chronic hyperglycaemic patients from neurological deterioration post-ischaemic stroke. Acta Neurol Scand, 137, 557–65Google Scholar

Mann, G, Hankey, GJ, Cameron, D. (1999). Swallowing function after stroke: prognosis and prognostic factors at 6 months. Stroke, 30, 744–8.Google Scholar

Manzanares, W, Aramendi, I, Langlois, PL, Biestro, A. (2015). Hyponatremia in the neurocritical care patient: an approach based on current evidence. Med Intensiva, 39, 234–43.Google Scholar

Marcantonio, ER. (2017). Delirium in hospitalized older adults. N Engl J Med, 377, 1456–66.Google Scholar

McCormick, MT, Muir, KW, Gray, CS, Walters, MR. (2008). Management of hyperglycemia in acute stroke: how, when, and for whom? Stroke, 39, 2177–85.Google Scholar

Middleton, S, McElduff, P, Ward, J, Grimshaw, JM, Dale, S, D’Este, C, et al., on behalf of the QASC Trialists Group. (2011). Implementation of evidence-based treatment protocols to manage fever, hyperglycemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomized controlled trial. Lancet, 378, 1699–706.Google Scholar

Naccarato, M1, Chiodo Grandi, F, Dennis, M, Sandercock, PA. (2010). Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev, 8, CD001922. doi:10.1002/14651858.CD001922.pub3.Google Scholar

Palli, C, Fandler, S, Doppelhofer, K, Niederkorn, K, Enzinger, C, Vetta, C, et al. (2017). Early dysphagia screening by trained nurses reduces pneumonia rate in stroke patients: a clinical intervention study. Stroke, 48, 2583–5.Google Scholar

Panfili, Z, Metcalf, M, Griebling, TL. (2017). Contemporary evaluation and treatment of poststroke lower urinary tract dysfunction. Urol Clin North Am, 44, 403–14.Google Scholar

Poisson, SN, Johnston, SC, Josephson, SA. (2010). Urinary tract infections complicating stroke: Mechanisms, consequences, and possible solutions. Stroke, 41, e180–4.Google Scholar

Powers, WJ, Rabinstein, AA, Ackerson, T, Adeoye, OM, Bambakidis, NC, Becker, K, et al.; American Heart Association Stroke Council. (2018). 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 49, e46–e110.Google Scholar

Prasad, K, Krishnan, PR. (2010). Fever is associated with doubling of odds of short-term mortality in ischemic stroke: an updated meta-analysis. Acta Neurol Scand, 122, 404–8.Google Scholar

Rai, N, Prasad, K, Bhatia, R, Vibha, D, Singh, MB, Rai, VK, Kumar, A. (2016). Development and implementation of acute stroke care pathway in a tertiary care hospital in India: a cluster-randomized study. Neurol India, 64(suppl), S39–S45.Google Scholar

Reith, J, Jorgensen, HS, Pedersen, PM, Nakayama H, Raaschou HO, Jeppesen LL, et al. (1996). Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet, 347, 422–5.CrossRefGoogle ScholarPubMed

RIGHT-2 Investigators. (2019). Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet, 393, 1009–20.Google Scholar

Roffe, C, Sills, S, Halim, H, Wilde K, Allen MB, Jones PW, et al. (2003). Unexpected nocturnal hypoxia in patients with acute stroke. Stroke, 34, 2641–5.Google Scholar

Roffe, C, Nevatte, T, Sim, J, Bishop, J, Ives, N, Ferdinand, P, et al. (2017). Effect of routine low-dose oxygen supplementation on death and disability in adults with acute stroke: The Stroke Oxygen Study randomized clinical trial. JAMA, 318, 1125–35.Google Scholar

Rowat, A, Graham, C, Dennis, M. (2012). Dehydration in hospital-admitted stroke patents: Detection, frequency, and association. Stroke, 43, 857–9.CrossRefGoogle Scholar

Saint, S, Kaufman, SR, Rogers, MAM, Baker, PD, Ossenkop, K, Lipsky, BA. (2006). Condom versus indwelling urinary catheters: a randomized trial. J Am Geriatr Soc, 54, 1055–61.Google Scholar

Sandercock, PAG, Counsell, C, Kane, EJ. (2015). Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev, 3, CD000024. doi:10.1002/14651858.CD000024.pub4.CrossRefGoogle ScholarPubMed

Sandercock, PAG, Counsell, C, Tseng, MC, Cecconi, E. (2014). Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev, 3, CD000029. doi:10.1002/14651858.CD000029.pub3.Google Scholar

Schmidt, JF, Waldemar, G, Vorstrup, S, Andersen, AR, Gjerris, F, Paulson, OB. (1990). Computerised analysis of cerebral blood flow autoregulation in humans: validation of a method for pharmacologic studies. J Cerebrovasc Pharmacol, 15, 983–8.Google Scholar

Schwarz, S, Georgiadis, D, Aschoff, A, Schwab, S. (2002). Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke, 33, 497–501.Google Scholar

Shi, Q, Presutti, R, Selchen, D, Saposnik, G. (2012). Delirium in acute stroke: a systematic review and meta-analysis. Stroke, 43, 645–9.Google Scholar

Siddiqi, N, Harrison, JK, Clegg, A, Teale, EA, Young, J, Taylor, J, et al. (2016). Interventions for preventing delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev, 3, CD005563. doi:10.1002/14651858.CD005563.pub3.Google Scholar

Stayman, A, Abou-Khalil, BW, Lavin, P, Azar, NJ. (2013). Homonymous hemianopia in nonketotic hyperglycemia is an ictal phenomenon. Neurol Clin Pract, 3, 392–7.Google Scholar

Steiner, T, Mendoza, G, De Georgia, M, Schellinger, P, Holle, R, Hacke, R. (1997). Prognosis of stroke patients requiring mechanical ventilation in a neurological critical care unit. Stroke, 28, 711–15.Google Scholar

Strandgaard, S, Olesen, J, Skinhøj, E, Lassen, NA. (1973). Autoregulation of brain circulation in severe arterial hypertension. Br Med J, 1, 507–10.Google Scholar

Strowd, RE, Wabnitz, A, Balakrishnan, N, Craig, J, Tegeler, CH. (2014). Clinical reasoning: acute-onset homonymous hemianopia with hyperglycemia. Neurology, 82, e129–33.Google Scholar

Sulter, G, Elting, JW, Stewart, R, den Arend, A, De Keyser, J. (2000). Continuous pulse oximetry in acute hemiparetic stroke. J Neurol Sci, 179, 65–9.Google Scholar

Sumer, M, Ozdemir, I, Erturk, O. (2003). Progression in acute ischemic stroke: frequency, risk factors and prognosis. J Clin Neurosci, 10, 177–80.Google Scholar

Suntrup, S, Marian, T, Schroder, JB, Suttrup, I, Muhle, P, Oelenberg, S, et al. (2015). Electrical pharyngeal stimulation for dysphagia treatment in tracheotomized stroke patients: a randomized controlled trial. Intensive Care Med, 41, 1629–37.Google Scholar

Suwanwela, NC, Chutinet, A, Mayotarn, S, Thanapiyachaikul, R, Chaisinanunkul, N, Asawavichienjinda, T, et al. (2017). A randomized controlled study of intravenous fluid in acute ischemic stroke. Clin Neurol Neurosurg, 161, 98–103.Google Scholar

Tyson, SF, Nightingale, P. (2004). The effects of position on oxygen saturation in acute stroke: a systematic review. Clin Rehabil, 18, 863–71.Google Scholar

Vermeij, FH, Scholte op Reimer, WJM, de Man, P, van Oostenbrugge, RJ, Franke, CL, de Jong, G, et al., and the Netherlands Stroke Survey Investigators. (2009). Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis, 27, 465–71.Google Scholar

Vermeij, JD, Westendorp, WF, Dippel, DW, van de Beek, D, Nederkoorn, PJ. (2018). Antibiotic therapy for preventing infections in people with acute stroke. Cochrane Database Syst Rev, 1, CD008530. doi:10.1002/14651858.CD008530.pub3.Google Scholar

von Kummer, R, Broderick, JP, Campbell, BC, Demchuk, A, Goyal, M, Hill, MD, et al. (2015). The Heidelberg Bleeding Classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke, 46, 2981–6.Google Scholar

Weimar, C, Mieck, T, Buchthal, J, Ehrenfeld, CE, Schmid, E, Diener H-C, MD, for the German Stroke Study Collaboration. (2005). Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol, 62, 393–7.Google Scholar

Williams, LS, Rotich, J, Qi, R, Fineberg, A, Espay, A, Bruno, SE, et al. (2002). Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology, 59, 67–71.Google Scholar

Wojner-Alexandrov, AW, Garami, Z, Chernyshev, OY, Alexandrov, AV. (2005). Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology, 64, 1354–7.Google Scholar

Ye, Q, Xie, Y, Shi, J, Xu, Z, Ou, A, Xu, N. (2017). Systematic review on acupuncture for treatment of dysphagia after stroke. Evid Based Complement Alternat Med, 6421852. doi:10.1155/2017/6421852.Google Scholar

Yoo, SH, Kim, JS, Kwon, SU, Yun, SC, Koh, JY, Kang, DW. (2008). Undernutrition as a predictor of poor clinical outcomes in acute ischemic stroke patients. Arch Neurol, 65, 39–43.CrossRefGoogle ScholarPubMed

Acker, JE III, Pancioli, AM, Crocco, T J, Eckstein, MK, Jauch, EC, Larrabee, H, et al. (2007). Implementation strategies for emergency medical services within stroke systems of care: a policy statement from the American Heart Association/ American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council. Stroke, 38(11), 3097–115.CrossRefGoogle Scholar

Adeoye, O, Sucharew, H, Khoury, J, Vagal, A, Schmit, PA, Ewing, I, et al. (2015). Combined approach to lysis utilizing eptifibatide and recombinant tissue-type plasminogen activator in acute ischemic stroke-full dose regimen stroke trial. Stroke, 46(9), 2529–33.Google Scholar

Alberts, MJ, Latchaw, RE, Jagoda, A, Wechsler, LR, Crocco, T, George, MG, et al. (2011). Revised and updated recommendations for the establishment of primary stroke centers: a summary statement from the brain attack coalition. Stroke, 42(9), 2651–65.Google Scholar

Alexandrov, AV, Kohrmann, M, Soinne, L, Mandava, P, Barreto, AD, Demchuk, AM, et al. (2016). Ultrasound enhanced thrombolysis for ischemic stroke: results of a multi-national phase iii trial – CLOTBUSTER. Paper presented at the European Stroke Organization Conference, Barcelona, Spain.Google Scholar

American College of Emergency Physicians; American Academy of Neurology (2013). Clinical policy: use of intravenous tPA for the management of acute ischemic stroke in the emergency department. Ann Emerg Med, 61, 225–43.Google Scholar

Anderson, CS, Robinson, T, Lindley, RI, Arima, H, Lavados, PM, Lee, TH, et al.; Investigators and Coordinators. (2016). Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med, 374(24), 2313–23.Google Scholar

Ankolekar, S, Fuller, M, Cross, I, Renton, C, Cox, P, Sprigg, N, et al. (2013). Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke, 44(11), 3120–8.Google Scholar

Atallah, AM. (2012). Consensus on Diagnosis and Treatment of Acute Ischemic Stroke Council – Argentine Society of Cardiology. Argentine J Cardiol, 80, 389–404.Google Scholar

Audebert, HJ, Schenkel, J, Heuschmann, PU, Bogdahn, U, Haberl, RL. (2006). Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol, 5(9), 742–8.Google Scholar

Barreto, AD, Alexandrov, AV, Lyden, P, Lee, J, Martin-Schild, S, Shen, L, et al. (2012). The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study. Stroke, 43(3), 770–5.Google Scholar

Bath, PM, Lees, KR, Schellinger, PD, Altman, H, Bland, M, Hogg, C, et al. (2012). Statistical analysis of the primary outcome in acute stroke trials. Stroke, 43(4), 1171–8.Google Scholar

Bendszus, M, Donnan, G, Hacke, W, Molina, C, Leys, D, Ringleb, P, et al.; ECASS-4 Collaborators. (2018). ECASS-4:EXTEND: Extending the Time for Thrombolysis in Emergency Neurological Deficits. Eur Stroke J, 3(Suppl 1), 4 (abstract).Google Scholar

Bivard, A, Huang, X, Levi, CR, Spratt, N, Campbell, BCV, Cheripelli, BK, et al. (2017). Tenecteplase in ischemic stroke offers improved recanalization: analysis of 2 trials. Neurology, 89(1), 62–7.Google Scholar

Bluhmki, E, Chamorro, A, Davalos, A, Machnig, T, Sauce, C, Wahlgren, N, et al. (2009). Stroke treatment with alteplase given 3.0–4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol, 8(12), 1095–1102.Google Scholar

Bryer, A, Connor, M, Haug, P, Cheyip, B, Staub, H, Tipping, B, et al. (2010). South African guideline for management of ischaemic stroke and transient ischaemic attack 2010: a guideline from the South African Stroke Society (SASS) and the SASS Writing Committee. S Afr Med J, 100(11 Pt 2), 747–78.Google Scholar

Campbell, BC; E-IT Investigators. (2018). Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): a multicenter, randomized, controlled trial. Paper presented at the International Stroke Conference, Los Angeles, CA.Google Scholar

Chao, AC, Liu, CK, Chen, CH, Lin, HJ, Liu, CH, Jeng, JS, et al. (2014). Different doses of recombinant tissue-type plasminogen activator for acute stroke in Chinese patients. Stroke, 45(8), 2359–65.Google Scholar

Cho, KH, Ko, SB, Kim, SH, Park, HK, Cho, AH, Hong, KS, et al. (2012). Focused update of Korean Clinical Practice Guidelines for the Thrombolysis in Acute Stroke Management. Korean J Stroke, 14, 95–105.Google Scholar

Ciccone, A, Motto, C, Aritzu, E, Piana, A, Candelise, L. (2000). Negative interaction of aspirin and streptokinase in acute ischemic stroke: further analysis of the Multicenter Acute Stroke Trial – Italy. Cerebrovasc Dis, 10(1), 61–4.Google Scholar

Daffertshofer, M, Gass, A, Ringleb, P, Sitzer, M, Sliwka, U, Els, T, et al. (2005). Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. Stroke, 36(7), 1441–6.Google Scholar

Davis, SM, Donnan, GA, Parsons, MW, Levi, C, Butcher, KS, Peeters, A, et al. (2008). Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol, 7(4), 299–309.Google Scholar

DeMers, G, Meurer, WJ, Shih, R, Rosenbaum, S, Vilke, GM. (2012). Tissue plasminogen activator and stroke: review of the literature for the clinician. J Emerg Med 43(6): 1149–1154.Google Scholar

Diener, HC, Foerch, C, Riess, H, Rother, J, Schroth, G, Weber, R. (2013). Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment. Lancet Neurol, 12(7), 677–88.Google Scholar

Emberson, J, Lees, KR, Lyden, P, Blackwell, L, Albers, G, Bluhmki, E, et al. (2014). Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet, 384, 1929–35.Google Scholar

European Stroke Organization Executive Committee and the ESO Writing Committee. (2008). Guidelines for the Management of Ischaemic Stroke and Transient Ischemic Attack 2008. www.eso-stroke.org/pdf/ESO08_Guidelines_Original_english.pdf. Accessed July 2013.Google Scholar

Fassbender, K, Grotta, JC, Walter, S, Grunwald, IQ, Ragoschke-Schumm, A, Saver, J. (2017). Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. Lancet Neurol, 16(3), 227–37.CrossRefGoogle ScholarPubMed

Feigin, VL, Norrving, B, Mensah, GA. (2017). Global burden of stroke. Circ Res, 120(3), 439–48.Google Scholar

Fischer, U, Kaesmacher, J, Mendes Pereira, V, Chapot, R, Siddiqui, AH, Froehler, MT, et al. (2017). Direct mechanical thrombectomy versus combined intravenous and mechanical thrombectomy in large-artery anterior circulation stroke: a topical review. Stroke, 48(10), 2912–18.Google Scholar

Fisher, M, Saver, JL. (2015). Future directions of acute ischaemic stroke therapy. Lancet Neurol, 14(7), 758–67.Google Scholar

Flynn, D, Nesbitt, DJ, Ford, GA, McMeekin, P, Rodgers, H, Price, C, et al. (2015). Development of a computerised decision aid for thrombolysis in acute stroke care. BMC Med Inform Decis Mak, 15(1), 6.Google Scholar

Fonarow, GC, Cox, M, Smith, E, Saver, J, Reeves, M, Bhatt, D, et al. (2017). Abstract 86: progress in achieving more rapid door-to-needle times in acute ischemic stroke: interim findings from target: stroke phase II. Stroke, 48(Suppl 1), A86.Google Scholar

Fonarow, GC, Smith, EE, Saver, JL, Reeves, MJ, Bhatt, DL, Grau-Sepulveda, MV, et al. (2011a). Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation, 123(7), 750–8.Google Scholar

Fonarow, GC, Smith, EE, Saver, JL, Reeves, MJ, Hernandez, AF, Peterson, ED, et al. (2011b). Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association’s Target: Stroke initiative. Stroke, 42(10), 2983–9.Google Scholar

Gadhia, J, Starkman, S, Ovbiagele, B, Ali, L, Liebeskind, D, Saver, JL. (2010). Assessment and improvement of figures to visually convey benefit and risk of stroke thrombolysis. Stroke, 41(2), 300–6.Google Scholar

Goyal, M., Menon, BK, van Zwam, WH, Dippel, DW, Mitchell, PJ, Demchuk, AM, et al. (2016). Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet, 387(10029), 1723–31.CrossRefGoogle ScholarPubMed

Grotta, J. (2001). Combination therapy stroke trial: recombinant tissue-type plasminogen activator with/without lubeluzole. Cerebrovasc Dis, 12(3), 258–63.Google Scholar

Hacke, W, Lyden, P, Emberson, J, Baigent, C, Blackwell, L, Albers, G, et al; Stroke Thrombolysis Trialists’ Collaborators. (2018). Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials. Int J Stroke, 13(2), 175–89.Google Scholar

Higashida, R, Alberts, MJ, Alexander, DN, Crocco, TJ, Demaerschalk, BM, Derdeyn, CP, et al. (2013). Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke, 44(10), 2961–84.Google Scholar

Hill, MD, Buchan, AM. (2005). Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ, 172(10), 1307–12.Google Scholar

Hougaard, KD, Hjort, N, Zeidler, D, Sorensen, L, Norgaard, A, Hansen, TM, et al. (2014). Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke, 45(1), 159–67.Google Scholar

Huang, X, MacIsaac, R, Thompson, JL, Levin, B, Buchsbaum, R, Haley, EC Jr., Levi, C, et al. (2016). Tenecteplase versus alteplase in stroke thrombolysis: an individual patient data meta-analysis of randomized controlled trials. Int J Stroke, 11(5), 534–43.CrossRefGoogle ScholarPubMed

Hughes, S. (2017). NOR-TEST: tenecteplase similar to alteplase in stroke. Medscape.Google Scholar

IST-3 Collaborative Group. (2015). Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial. Lancet Neurol, 14(5), 485–96.Google Scholar

Jauch, EC, Saver, JL, Adams, HP Jr., Bruno, A, Connors, JJ, Demaerschalk, BM, et al. (2013). Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 44(3), 870–947.Google Scholar

Kermer, P, Eschenfelder, CC, Diener, HC, Grond, M, Abdalla, Y, Althaus, K, et al. (2017). Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany – a national case collection. Int J Stroke, 12(4), 383–91.Google Scholar

Khatri, P, Kleindorfer, DO, Devlin, T, Sawyer, RN Jr, Starr, M, Mejilla, J, et al.; P. Investigators. (2018). Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits: the PRISMS randomized clinical trial. JAMA, 320(2), 156–66.Google Scholar

Kim, BJ, Han, MK, Park, TH, Park, SS, Lee, KB, Lee, BC, et al. (2015). Low-versus standard-dose alteplase for ischemic strokes within 4.5 hours: a comparative effectiveness and safety study. Stroke, 46(9), 2541–8.Google Scholar

Kim, JT, Fonarow, GC, Smith, EE, Reeves, MJ, Navalkele, DD, Grotta, JC, et al. (2017). treatment with tissue plasminogen activator in the golden hour and the shape of the 4.5-hour time-benefit curve in the national United States Get with the Guidelines-Stroke population. Circulation, 135(2), 128–39.Google Scholar

Lansberg, MG, Schrooten, M, Bluhmki, E, Thijs, VN, J. L. Saver, JL. (2009). Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke, 40(6), 2079–84.Google Scholar

Lees, KR, Emberson, J, Blackwell, L, Bluhmki, E, Davis, SM, Donnan, GA, et al.; Stroke Thrombolysis Trialists’ Collaborators. (2016). Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke, 47(9), 2373–9.Google Scholar

Legrand, L, Naggara, O, Turc, G, Mellerio, C, Roca, P, Calvet, D, et al. (2013). Clot burden score on admission T2*-MRI predicts recanalization in acute stroke. Stroke, 44(7), 1878–84.Google Scholar

Liberatore, GT,. Samson, A, Bladin, C, Schleuning, WD, Medcalf, RL. (2003). Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke, 34(2), 537–43.Google Scholar

Lindley, RI, Wardlaw, JM, Whiteley, WN, Cohen, G, Blackwell, L, Murray, GD, et al.; ISTC Group (2015). Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial. Stroke, 46(3), 746–56.Google Scholar

Lindsay, P, Bayley, M, McDonald, A, Graham, ID, Warner, G, Phillips, S. (2008). Toward a more effective approach to stroke: Canadian Best Practice Recommendations for Stroke Care. CMAJ, 178(11), 1418–25.Google Scholar

Logallo, N, Novotny, V, Assmus, J, Kvistad, CE, Alteheld, L, Ronning, OM, et al. (2017). Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial. Lancet Neurol, 16(10), 781–8.Google Scholar

Lorenzano, S, Toni, D, (2017). TESPI (Thrombolysis in elderly stroke patients in Italy). Paper presented at the European Stroke Organization Conference, Prague, Czech Republic.Google Scholar

Luo, S, Zhuang, M, Zeng, W, Tao, J. (2016). Intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy: a systematic review and meta-analysis of 19 studies. J Am Heart Assoc, 5(5), e003242.Google Scholar

Lyden, P, Jacoby, M, Schim, J, Albers, G, Mazzeo, P, Ashwood, T, et al. (2001). The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results. Neurology, 57, 1199–1205.Google Scholar

Ma, H, Campbell, BCV, Parsons, MW, Churilov, L, Levi, CR, Hsu, C, et al.; EXTEND Investigators. (2019). Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med, 380(19), 1795–1803.Google Scholar

Meretoja, A, Strbian, D, Mustanoja, S, Tatlisumak, T, Lindsberg, PJ, Kaste, M. (2012). Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology, 79(4), 306–13.Google Scholar

Montero, M, Tokunboh, I, Sharma, L, Szeder, SV, AM LD, Lansberg, M, et al. (2017). Harmonized visual decision aids to expedite physician, patient, and family decision-making regarding intravenous tPA for acute ischemic stroke in different time windows. Eur Stroke J, 2(IS), 155.Google Scholar

Mori, E, Minematsu, K, Nakagawara, J, Hasegawa, Y, Nagahiro, S, Okada, Y, Truelsen, T, et al.; D.-J. Investigators (2015). Safety and tolerability of desmoteplase within 3 to 9 hours after symptoms onset in Japanese patients with ischemic stroke. Stroke, 46(9), 2549–54.Google Scholar

Nacu, A, Kvistad, CE, Naess, H, Oygarden, H, Logallo, N, J.Assmus, J, et al. (2017). NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): randomized controlled contrast-enhanced sonothrombolysis in an unselected acute ischemic stroke population. Stroke, 48(2), 335–41.Google Scholar

Nakagawara, J, Minematsu, K, Okada, Y, Tanahashi, N, Nagahiro, S, Mori, E, et al. (2010). Thrombolysis with 0.6 mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice: the Japan post-Marketing Alteplase Registration Study (J-MARS). Stroke, 41(9), 1984–9.Google Scholar

National Institute for Health and Clinical Excellence (NICE) – National Health Services. (2007). Final appraisal determination: alteplase for the treatment of acute ischaemic stroke. www.nice.org.uk/nicemedia/pdf/StokeAteplFAD.pdf. Accessed October 2009.Google Scholar

NINDS t-PA Stroke Trial Study Group. (1997). Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke, 28(11), 2119–25.Google Scholar

Pancioli, AM, Adeoye, O, Schmit, PA, Khoury, J, Levine, SR, Tomsick, TA, et al.; and C.-E. Investigators. (2013). Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke – enhanced regimen stroke trial. Stroke, 44(9): 2381–7.Google Scholar

Pancioli, AM, Broderick, J, Brott, T, Tomsick, T, Khoury, J, Bean, J, et al. (2008). The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke, 39(12), 3268–76.Google Scholar

Parsons, M, Spratt, N, Bivard, A, Campbell, B, Chung, K, Miteff, F, et al. (2012). A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med, 366(12), 1099–1107.Google Scholar

Picanco, MR, Christensen, S, Campbell, BC, Churilov, L, Parsons, MW, Desmond, PM, et al. (2014). Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes. Int J Stroke, 9(3), 266–9.Google Scholar

Pikija, S, Sztriha, LK, Sebastian Mutzenbach, J, Golaszewski, SM, Sellner, J. (2017). Idarucizumab in dabigatran-treated patients with acute ischemic stroke receiving alteplase: a systematic review of the available evidence. CNS Drugs, 31(9), 747–57.Google Scholar

Reddrop, C, Moldrich, RX, Beart, PM, Farso, M, Liberatore, GT, Howells, DW, et al. (2005). Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury. Stroke, 36(6), 1241–6.Google Scholar

Sanossian, N. (2017). Before the angiography suite: prehospital stroke identification, routing, and treatment. Endovascular Today, 16, 45–52.Google Scholar

Saposnik, G, Gladstone, D, Raptis, R, Zhou, L, Hart, RG; Investigators of the Registry of the Canadian Stroke Network and the Stroke Outcomes Research Canada Working Group. (2013). Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke, 44(1), 99–104.Google Scholar

Saqqur, M, Tsivgoulis, G, Nicoli, F, Skoloudik, D, Sharma, VK, Larrue, V, et al. (2014). The role of sonolysis and sonothrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials and case-control studies. J Neuroimaging, 24(3), 209–20.Google Scholar

Saver, JL. (2011). Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices. Stroke, 42(8), 2356–62.Google Scholar

Saver, JL, Fonarow, GC, Smith, EE, Reeves, MJ, Grau-Sepulveda, MV, Pan, W, et al. (2013). Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA, 309(23), 2480–8.Google Scholar

Saver, JL, Gornbein, J, Grotta, J, Liebeskind, D, Lutsep, H, Schwamm, L, et al. (2009). Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial. Stroke, 40(7), 2433–7.Google Scholar

Seiffge, DJ, Hooff, RJ, Nolte, CH, Bejot, Y, Turc, G, Ikenberg, B, et al. (2015). Recanalization therapies in acute ischemic stroke patients: impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome. Circulation, 132(13), 1261–9.Google Scholar

Sharma, M, Clark, H, Armour, T, Stotts, G, Coté, R, Hill, MD, et al. (2005). Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Summ), 127, 1–7.Google Scholar

Shobha, N., Fang, J, Hill, MD. (2013). Do lacunar strokes benefit from thrombolysis? Evidence from the Registry of the Canadian Stroke Network. Int J Stroke, 8 (Suppl A100), 45–49.Google Scholar

Thomalla, G, Simonsen, CZ, Boutitie, F, Andersen, G, Berthezene, Y, Cheng, B, et al.; W.-U. Investigators. (2018). MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med, 379(7), 611–22.Google Scholar

Tong, X, Liao, X, Pan, Y, Cao, Y, Wang, C, Liu, C, et al. (2016). Intravenous thrombolysis is more safe and effective for posterior circulation stroke: Data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China). Medicine (Baltimore), 95(24), e3848.Google Scholar

von Kummer, R, Mori, E, Truelsen, T, Jensen, JS, Gronning, BA, Fiebach, JB, et al. (2016). Desmoteplase 3 to 9 hours after major artery occlusion stroke: the DIAS-4 Trial (efficacy and safety study of desmoteplase to treat acute ischemic stroke). Stroke, 47(12), 2880–87.Google Scholar

Wahlgren, N, Ahmed, N. (2016). SITS Report 2016. Stockholm: SITS International Coordination Team.Google Scholar

Warach, S, Al-Rawi, Y, Furlan, AJ, Fiebach, JB, Wintermark, M, Lindsten, A, et al. (2012). Refinement of the magnetic resonance diffusion-perfusion mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials. Stroke, 43(9), 2313–18.Google Scholar

Wardlaw, JM, Koumellis, P, Liu, M. (2013). Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke. Cochrane Database Syst Rev, 5, CD000514.Google Scholar

Wardlaw, JM, Murray, V, Berge, E, del Zoppo, GJ. (2014). Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 7, CD000213.Google Scholar

Wechsler, LR, Demaerschalk, BM, Schwamm, LH, Adeoye, OM, Audebert, HJ, Fanale, CV, et al. (2017). Telemedicine quality and outcomes in stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 48(1), e3–e25.Google Scholar

Wheeler, HM, Mlynash, M, Inoue, M, Tipirnini, A, Liggins, J, Bammer, R, et al. (2015). The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion. Int J Stroke, 10(5), 723–9.Google Scholar

Whiteley, WN, Emberson, J, Lees, KR, Blackwell, L, Albers, G, Bluhmki, E, et al; Stroke Thrombolysis Trialists. (2016). Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. Lancet Neurol, 15(9), 925–33.Google Scholar

Wright, L, Hill, KM, Bernhardt, J, Lindley, R, Ada, L, Bajorek, BV, et al. (2012). Stroke management: updated recommendations for treatment along the care continuum. Intern Med J, 42(5), 562–9.Google Scholar

Xian, Y, Federspiel, JJ, Hernandez, AF, Laskowitz, DT, Schwamm, LH, Bhatt, DL, et al. (2017a). Use of intravenous recombinant tissue plasminogen activator in patients with acute ischemic stroke who take non-vitamin K antagonist oral anticoagulants before stroke. Circulation, 135(11), 1024–35.Google Scholar

Xian, Y, Liang, L, Smith, EE, Schwamm, LH, Reeves, MJ, Olson, DM, et al. (2012). Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA, 307(24), 2600–8.Google Scholar

Xian, Y, Xu, H, Lytle, B, Blevins, J, Peterson, ED, Hernandez, AF, et al. (2017b). Use of strategies to improve door-to-needle times with tissue-type plasminogen activator in acute ischemic stroke in clinical practice: findings from Target: Stroke. Circ Cardiovasc Qual Outcomes, 10(1).Google Scholar

Yayan, J. (2013). Onset of orolingual angioedema after treatment of acute brain ischemia with alteplase depends on the site of brain ischemia: a meta-analysis. N Am J Med Sci, 5(10), 589–93.Google Scholar

Zinkstok, SM, Roos, YB; ARTIS Investigators. (2012). Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet, 380(9843), 731–7.Google Scholar

Acker, JE III, Pancioli, AM, Crocco, TJ, Eckstein, MK, Jauch, EC, Larrabee, H, et al. (2007). Implementation strategies for emergency medical services within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association Expert Panel on Emergency Medical Services Systems and the Stroke Council. Stroke, 38(11), 3097–115.Google Scholar

Al-Mufti, F, Amuluru, K, Roth, W, Nuoman, R, El-Ghanem, M, Meyers, PM. (2018). Cerebral ischemic reperfusion injury following recanalization of large vessel occlusions. Neurosurgery, 82(6), 781–9.Google Scholar

American Heart/Stroke Association Mission Lifeline Stroke Committee. (2017). Severity-based stroke triage algorithm for EMS. www.heart.org/idc/groups/ahaecc-public/@wcm/@gwtg/documents/downloadable/ucm_492025.pdf. Accessed March 2017.Google Scholar

Badhiwala, JH, Nassiri, F, Alhazzani, W, Selim, MH, Farrokhyar, F, Spears, J, et al. (2015). Endovascular thrombectomy for acute ischemic stroke: a meta-analysis. JAMA, 314(17), 1832–43.Google Scholar

Bath, PM, Lees, KR, Schellinger, PD, Altman, H, Bland, M, Hogg, C, et al. (2012). Statistical analysis of the primary outcome in acute stroke trials. Stroke, 43(4), 1171–8.Google Scholar

Bendszus, M, Thomalla, G, Hacke, W, Knauth, M, Gerloff, C, Bonekamp, S, et al.; THRILL Investigators. (2016). Early termination of THRILL, a prospective study of mechanical thrombectomy in patients with acute ischemic stroke ineligible for i.v. thrombolysis. Clin Neuroradiol, 26(4), 499–500.Google Scholar

Berkhemer, OA, Fransen, PSS, Beumer, D, van den Berg, LA, Lingsma, HF, Yoo, AJ, et al. (2015). A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med, 372(1): 11–20.Google Scholar

Casaubon, L, Boulanger, J, Blacquiere, D, Bucher, S, Brown, K, Goddard, T, et al.; Heart and Stroke Foundation of Canada Canadian Stroke Best Practices Advisory Committee. (2015). Canadian Stroke Best Practice Recommendations: Hyperacute Stroke Care Guidelines, update 2015. Int J Stroke, 10(6), 924–40.Google Scholar

Chapman Smith, SN, Govindarajan, P, Padrick, MM, Lippman, JM, McMurry, TL, Resler, BL, et al. (2016). A low-cost, tablet-based option for prehospital neurologic assessment: The iTREAT Study. Neurology, 87(1), 19–26.Google Scholar

Ciccone, A, Valvassori, L, Nichelatti, M, Sgoifo, A, Ponzio, M, Sterzi, R, et al. (2013). Endovascular treatment for acute ischemic stroke. N Engl J Med, 368(10), 904–13.Google Scholar

Ciccone, A, Valvassori, L, Ponzio, M, Ballabio, E, Gasparotti, R, Sessa, M, et al. (2010). Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. J Neurointerv Surg, 2(1), 74–9.Google Scholar

Ducrocq, X, Bracard, S, Taillandier, L, Anxionnat, R, Lacour, JC, Guillemin, F, et al. (2005). Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke. J Neuroradiol, 32(1), 26–32.Google Scholar

Fassbender, K, J. C. Grotta, JC, S. Walter, S, Grunwald, IQ, Ragoschke-Schumm, A, Saver, JL. (2017). Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. Lancet Neurol, 16(3), 227–37.Google Scholar

Feigin, VL, Norrving, B, Mensah, GA. (2017). Global burden of stroke. Circ Res, 120(3), 439–48.Google Scholar

Goyal, M, Demchuk, AM, Menon, BK, Eesa, M, Rempel, JL, Thornton, J, et al.; ESCAPE Trial Investigators. (2015). Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med, 372(11), 1019–30.Google Scholar

Goyal, M, Menon, BK, Hill, MD, Demchuk, A. (2014). Consistently achieving computed tomography to endovascular recanalization <90 minutes: solutions and innovations. Stroke, 45(12), e252–6.Google Scholar

Goyal, M, Menon, BK, van Zwam, WH, Dippel, DW, Mitchell, PJ, Demchuk, AM, et al.; HERMES Collaborators. (2016). Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet, 387(10029), 1723–31.Google Scholar

Goyal, N, Tsivgoulis, G, Pandhi, A, Chang, JJ, K. Dillard, K, Ishfaq, MF, et al. (2017). Blood pressure levels post mechanical thrombectomy and outcomes in large vessel occlusion strokes. Neurology, 89(6), 540–7.Google Scholar

Herzberg, M, Boy, S, Holscher, T, Ertl, M, Zimmermann, M, Ittner, KP, et al. (2014). Prehospital stroke diagnostics based on neurological examination and transcranial ultrasound. Crit Ultrasound J, 6(1), 3.Google Scholar

Higashida, R, Alberts, MJ, Alexander, DN, Crocco, TJ, Demaerschalk, BM, Derdeyn, CP, et al. (2013). Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke, 44(10), 2961–84.Google Scholar

Hong, KS, Ko, SB, Yu, KH, Jung, C, Park, SQ, Kim, BM, et al. (2016). Update of the Korean Clinical Practice Guidelines for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke. J Stroke, 18(1), 102–13.Google Scholar

Jadhav, AP, Kenmuir, CL, Aghaebrahim, A, Limaye, K, Wechsler, LR, Hammer, MD, et al. (2017). Interfacility transfer directly to the neuroangiography suite in acute ischemic stroke patients undergoing thrombectomy. Stroke, 48(7), 1884–9.Google Scholar

Jauch, EC, Saver, JL, Adams, HP Jr., Bruno, A, Connors, JJ, Demaerschalk, BM, et al. (2013). Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 44(3), 870–947.Google Scholar

Jovin, TG, Chamorro, A, Cobo, E, de Miquel, MA, Molina, CA, Rovira, A, et al.; REVASCAT Trial Investigators. (2015). Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med, 372(24), 2296–306.Google Scholar

Kim, DH, Kim, B, Jung, C, Nam, HS, Lee, JS, Kim, JW, et al.; Korean Society of Interventional Neuroradiology and Korean Stroke Society Joint Task Force Team. (2018). Consensus statements by Korean Society of Interventional Neuroradiology and Korean Stroke Society: hyperacute endovascular treatment workflow to reduce door-to-reperfusion time. J Korean Med Sci, 33(19), e143.Google Scholar

Lapergue, B, Blanc, R, Gory, B, Labreuche, J, Duhamel, A, Marnat, G, et al.; ASTER Trial Investigators. (2017). Effect of endovascular contact aspiration vs stent retriever on revascularization in patients with acute ischemic stroke and large vessel occlusion: the ASTER randomized clinical trial. JAMA, 318(5), 443–52.Google Scholar

Legrand, L, Naggara, O, G. Turc, G, Mellerio, C, Roca, P, Calvet, D, et al. (2013). Clot burden score on admission T2*-MRI predicts recanalization in acute stroke. Stroke, 44(7), 1878–84.Google Scholar

Milne, MS, Holodinsky, JK, Hill, MD, Nygren, A, Qiu, C, Goyal, M, et al. (2017). Drip ‘n’ ship versus mothership for endovascular treatment: modeling the best transportation options for optimal outcomes. Stroke, 48(3), 791–4.Google Scholar

Mocco, J, Siddiqui, A, Turk, A. (2018). A comparison of direct aspiration vs. stent retriever as a first approach (COMPASS): a randomized trial. Paper presented at the International Stroke Conference, Los Angeles, CA. https://professional.heart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_498785.pdf. Accessed June 2018.Google Scholar

Muir, KW, Ford, GA, Messow, CM, Ford, I, Murray, A, Clifton, A, et al.; PISTE Investigators. (2017). Endovascular therapy for acute ischaemic stroke: the Pragmatic Ischaemic Stroke Thrombectomy Evaluation (PISTE) randomised, controlled trial. J Neurol Neurosurg Psychiatry, 88(1), 38–44.Google Scholar

Nogueira, RG, Frei, D, Kirmani, JF, Zaidat, O, Lopes, D, Turk, AS 3rd, et al.; Penumbra Separator 3D Investigators. (2018). Safety and efficacy of a 3-dimensional stent retriever with aspiration-based thrombectomy vs aspiration-based thrombectomy alone in acute ischemic stroke intervention: a randomized clinical trial. JAMA Neurol, 75(3), 304–11.Google Scholar

Nogueira, RG, Lutsep, HL, Gupta, R, Jovin, TG, Albers, GW, Walker, GA, et al. (2012). Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet, 380(9849), 1231–40.Google Scholar

Noorian, AR, Sanossian, N, Shkirkova, K, Liebeskind, DS, Eckstein, M, Stratton, SJ, et al.; FAST-MAG Trial Investigators and Coordinators. (2018). Los Angeles Motor Scale to identify large vessel occlusion: prehospital validation and comparison with other screens. Stroke, 49(3), 565–72.Google Scholar

Nour, M, Scalzo, F, Liebeskind, DS. (2013). Ischemia-reperfusion injury in stroke. Interv Neurol, 1(3–4), 185–99.Google Scholar

O’Rourke, K, Berge, E, Walsh, CD, Kelly, PJ. (2010). Percutaneous vascular interventions for acute ischaemic stroke. Cochrane Database Syst Rev, 10, CD007574.Google Scholar

Persson, M, Fhager, A, Trefna, HD, Yu, Y, McKelvey, T, Pegenius, G, et al. (2014). Microwave-based stroke diagnosis making global prehospital thrombolytic treatment possible. IEEE Trans Biomed Eng, 61(11), 2806–17.Google Scholar

Pontes-Neto, OM, Cougo, P, Martins, SC, Abud, DG, Nogueira, RG, Miranda, M, et al. (2017). Brazilian guidelines for endovascular treatment of patients with acute ischemic stroke. Arq Neuropsiquiatr, 75(1), 50–6.Google Scholar

Powers, WJ, Rabinstein, AA, Ackerson, T, Adeoye, OM, Bambakidis, NC, Becker, K, et al.; American Heart Association Stroke Council. (2018). 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 49(3), e46–110.Google Scholar

Rajajee, V, Kidwell, C, Starkman, S, Ovbiagele, B, Alger, JR, Villablanca, P, et al. (2006). Early MRI and outcomes of untreated patients with mild or improving ischemic stroke. Neurology, 67(6), 980–4.Google Scholar

Ribo, M.; RACECAT Trialists. (2017). Direct transfer to an endovascular center compared to transfer to the closest stroke center in acute stroke patients with suspected large vessel occlusion (RACECAT). NCT02795962. https://clinicaltrials.gov/ct2/show/NCT02795962. Accessed June 2018.Google Scholar

Rodrigues, FB, Neves, JB, Caldeira, D, Ferro, JM, Ferreira, JJ, Costa, J. (2016). Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ, 353, i1754.Google Scholar

Saver, JL. (2011). Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices. Stroke, 42(8), 2356–62.Google Scholar

Saver, JL. (2013). The 2012 Feinberg lecture: treatment swift and treatment sure. Stroke, 44(1), 270–7.Google Scholar

Saver, JL, Goyal, M, van der Lugt, A, Menon, BK, Majoie, CB, Dippel, DW, et al.; HERMES Collaborators. (2016). Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA, 316(12), 1279–88.Google Scholar

Saver, JL, Jahan, R, Levy, EI, Jovin, TG, Baxter, B, Nogueira, RG, et al. (2012). Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet, 380(9849), 1241–9.Google Scholar

Smith, EE, Kent, DM, Bulsara, KR, Leung, LY, Lichtman, JH, Reeves, MJ, et al.; American Heart Association Stroke Council. (2018). Accuracy of prediction instruments for diagnosing large vessel occlusion in individuals with suspected stroke: a systematic review for the 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke. Stroke, 49(3), e111–22.Google Scholar

Tokunboh, I, Vales Montero, M, Zopelaro Almeida, MF, Sharma, L, Starkman, S, Szeder, V, et al. (2018). Visual aids for patient, family, and physician decision making about endovascular thrombectomy for acute ischemic stroke. Stroke, 49(1), 90–7.Google Scholar

Ventz, S, Barry, WT, Parmigiani, G, Trippa, L. (2017). Bayesian response-adaptive designs for basket trials. Biometrics, 73(3), 905–15.Google Scholar

Wahlgren, N, Moreira, T, Michel, P, Steiner, T, Jansen, O, Cognard, C, et al. (2016). Mechanical thrombectomy in acute ischemic stroke: consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN. Int J Stroke, 11(1), 134–47.Google Scholar

Wang, H, Thevathasan, A, Dowling, R, Bush, S, Mitchell, P, Yan, B. (2017). Streamlining workflow for endovascular mechanical thrombectomy: lessons learned from a comprehensive stroke center. J Stroke Cerebrovasc Dis, 26(8), 1655–62.Google Scholar

Wardlaw, JM, Murray, V, Berge, E, del Zoppo, GJ. (2014). Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 7, CD000213.Google Scholar

Wheeler, HM, Mlynash, M, Inoue, M, Tipimini, A, Liggins, J, Bammer, R, et al.; DEFUSE 2 Investigators. (2015). The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion. Int J Stroke, 10(5), 723–9.Google Scholar

Zaidat, OO, Bozorgchami, H, Ribo, M, Saver, JL, Mattle, HP, Chapot, R, et al. (2018a). Primary results of the multicenter ARISE II study (Analysis of Revascularization in Ischemic Stroke with EmboTrap). Stroke, 49(5), 1107–15.Google Scholar

Zaidat, OO, Castonguay, AC, Linfante, I, Gupta, R, Martin, CO, Holloway, WE, et al. (2018b). First pass effect: a new measure for stroke thrombectomy devices. Stroke, 49(3): 660–6.Google Scholar

Anderson, CS, Huang, Y, Lindley, RI, Chen, X, Arima, H, Chen, G, et al.; ENCHANTED Investigators and Coordinators. (2019). Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial. Lancet, 393(10174), 877–88.Google Scholar

Asplund, K. (1991). Hemodilution in acute stroke. Cerebrovasc Dis, 1(Suppl. 1), 129–38.Google Scholar

Bath, PM, Appleton, JP, Krishnan, K, Sprigg, N. (2018). Blood pressure in acute stroke: to treat or not to treat: that is still the question. Stroke, 49(7), 1784–90.Google Scholar

Bath, PM, Bath-Hextall, FJ. (2004). Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke. Cochrane Database Syst Rev, 3. CD000162.Google Scholar

Bath, PM, Krishnan, K. (2014). Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev, 10. CD000039.Google Scholar

Berge, E, Cohen, G, Lindley, RI, Sandercock, P, Wardlaw, JM, Sandset, EC, et al. (2015). Effects of blood pressure and blood pressure-lowering treatment during the first 24 hours among patients in the third International Stroke Trial of thrombolytic treatment for acute ischemic stroke. Stroke, 46(12), 3362–9.Google Scholar

Chang, TS, Jensen, MB. (2014). Haemodilution for acute ischaemic stroke. Cochrane Database Syst Rev, 8. CD000103.Google Scholar

Hao, Z, Liu, M, Counsell, C, Wardlaw, JM, Lin, S, Zhao, X. (2012). Fibrinogen depleting agents for acute ischaemic stroke. Cochrane Database Syst Rev, 3. CD000091.Google Scholar

Immink, RV, van Montfrans, GA, Stam, J, Karemaker, JM, Diamant, M, van Lieshout, JJ. (2005). Dynamic cerebral autoregulation in acute lacunar and middle cerebral artery territory ischemic stroke. Stroke, 36(12), 2595–2600.Google Scholar

Leonardi-Bee, J, Bath, PM, Phillips, SJ,. Sandercock, PA. (2002). Blood pressure and clinical outcomes in the International Stroke Trial. Stroke, 33(5), 1315–20.Google Scholar

Powers, WJ, Rabinstein, AA, Ackerson, T, Adeoye, OM, Bambakidis, NC, Becker, K, et al.; American Heart Association Stroke Council. (2018). 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 49(3), e46–e110.Google Scholar

Qureshi, AI. (2008). Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation, 118(2), 176–87.Google Scholar

Qureshi, AI, Ezzeddine, MA, Nasar, A, Suri, MF, Kirmani, JF, Hussein, HM, et al. (2007). Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med, 25(1), 32–8.Google Scholar

RIGHT-2 Investigators. (2019). Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet, 393(10175), 1009–20.Google Scholar

Sandset, EC, Sanossian, N, Woodhouse, LJ, Anderson, C, Berge, E, Lees, KR, et al.; Blood Pressure in Acute Stroke Collaboration Investigators. (2018). Protocol for a prospective collaborative systematic review and meta-analysis of individual patient data from randomized controlled trials of vasoactive drugs in acute stroke: the Blood Pressure in Acute Stroke Collaboration, stage-3. Int J Stroke, 13(7), 759–65.Google Scholar

Strandgaard, S, Paulson, OB. (1984). Cerebral autoregulation. Stroke, 15(3), 413–16.Google Scholar

Vemmos, KN, Tsivgoulis, G, Spengos, K, Zakopoulos, N, Synetos, A, Manios, E, et al. (2004). U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med, 255(2), 257–65.Google Scholar

Wallace, JD, Levy, LL. (1981). Blood pressure after stroke. JAMA, 246(19), 2177–80.Google Scholar

Willmot, M, Ghadami, A, Whysall, B, Clarke, W, Wardlaw, J, Bath, PM. (2006). Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension, 47(6), 1209–15.Google Scholar

Woodhouse, LJ, Manning, L, Potter, JF, Berge, E, Sprigg, N, Wardlaw, J, et al; Blood Pressure in Acute Stroke Council. (2017). Continuing or temporarily stopping prestroke antihypertensive medication in acute stroke: an individual patient data meta-analysis. Hypertension, 69(5), 933–41.Google Scholar

Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators. (2005). Emergency administration of abciximab for treatment of patients with acute ischemic stroke. Results of a randomized phase 2 trial. Stroke, 36, 880–90.Google Scholar

Abciximab in Ischemic Stroke (AIST) Investigators. (2000). Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke, 31, 601–09.Google Scholar

Adams, HP Jr, Effron, MB, Torner, J, Davalos, A, Frayne, J, Teal, P, et al. (2008). Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke, 39, 87–99.Google Scholar

Adeoye, O, Sucharew, H, Khoury, J, Vagal, A, Schmit, PA, Ewing, I, et al. (2015). Combined approach to lysis utilizing eptifibatide and recombinant tissue-type plasminogen activator in acute ischemic stroke – full dose regimen stroke trial. Stroke, 46, 2529–33.Google Scholar

Bath, PM, Cotton, D, Martin, RH, Palesch, Y, Yusuf, S, Sacco, R, et al.; PRoFESS Study Group. (2010). Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke, 41, 732–8.Google Scholar

Bath, PM, Woodhouse, LJ, Appleton, JP, Beridze, M, Christensen, H, Dineen, RA, et al.; TARDIS Investigators. (2018). Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomized, open-label, phase 3 superiority trial. Lancet, 391, 850–9.Google Scholar

Berge, E, Abdelnoor, M, Nakstad, PH, Sandset, PM. (2000). Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet, 355, 1205–10.Google Scholar

Berge, E, Sandercock, PAG. (2002). Anticoagulants versus antiplatelet agents for acute ischaemic stroke. Cochrane Database Syst Rev, 4. CD003242.Google Scholar

CAST (Chinese Acute Stroke Trial) Collaborative Group. (1997). CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet, 349, 1641–9.Google Scholar

Chen, ZM, Sandercock, P, Pan, HC, Counsell, C, Collins, R, Liu, LS, et al. (2000). Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke, 31, 1240–9.Google Scholar

Ciccone, A, Motto, C, Abraha, I, Cozzolino, F, Santilli, I. (2014). Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke. Cochrane Database Syst Rev, 3. CD005208. doi:10.1002/14651858.CD005208.pub3.Google Scholar

Ciuffetti, G, Aisa, G, Mercuri, M, Lombardini, R, Paltriccia, R, Neri, C, et al. (1990). Effects of ticlopidine on the neurologic outcome and the hemorheologic pattern in the post acute phase of ischemic stroke: a pilot study. Angiology, 41, 505–11.Google Scholar

Cranston, JS, Kaplan, BD, Saver, JL. (2017). Minimally clinically important difference for safe and simple novel acute ischemic stroke therapies. Stroke, 48, 2946–51.Google Scholar

Dengler, R, Diener, H-C, Schwartz, A, Grond, M, Schumacher, H, Machnig, T, et al.; for the EARLY Investigators. (2010). Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Lancet Neurol, 9, 159–66.Google Scholar

He, F, Xia, C, Zhang, JH, Li, XQ, Zhou, ZH, Li, FP, et al. (2015). Clopidogrel plus aspirin versus aspirin alone for preventing early neurological deterioration in patients with acute ischemic stroke. J Clin Neurosci, 22, 83–6.Google Scholar

International Stroke Trial Collaborative Group. (1997). The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet, 349, 1569–81.Google Scholar

Jing, J, Meng, X, Zhao, X, Liu, L, Wang, A, Pan, Y, et al. (2018). Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns: subgroup analysis of the CHANCE randomized clinical trial. JAMA Neurol, 75, 711–19.Google Scholar

Johnston, SC, Amarenco, P, Albers, GW, Denison, H, Easton, JD, Evans, SR, et al; SOCRATES Steering Committee and Investigators. (2016). Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med, 375, 35–43.Google Scholar

Johnston, SC, Easton, JD, Farrant, M, Barsan, W, Conwit, RA, Elm, JJ, et al.; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. (2018). Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med, 379, 215–25.Google Scholar

Johnston, SC, Leira, EC, Hansen, MD, Adams, HP Jr. (2003). Early recovery after cerebral ischemia risk of subsequent neurological deterioration. Ann Neurol, 54, 439–44.Google Scholar

Kennedy, J, Hill, MD, Ryckborst, KJ, Eliasziw, M, Demchuk, AM, Buchan, AM; FASTER Investigators. (2007). Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol, 6, 961–9.Google Scholar

Lee, YS, Bae, HJ, Kang, DW, Lee, SH, Yu, K, Park, JM, et al. (2011). Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial. Cerebrovasc Dis, 32, 65–71.Google Scholar

Liu, L, Wong, KS, Leng, X, Pu, Y, Wang, Y, Jing, J, et al.; CHANCE Investigators. (2015). Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE. Neurology, 85, 1154–62.Google Scholar

Multicentre Acute Stroke Trial-Italy (MAST-I) Group. (1995). Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet, 346, 1509–14.Google Scholar

Pan, Y, Jing, J, Chen, W, Meng, X, Li, H, Zhao, X, Liu, L, Wang, D, Johnston, SC, Wang, Y, Wang, Y; CHANCE Investigators. (2017a). Risks and benefits of clopidogrel-aspirin in minor stroke or TIA: time course analysis of CHANCE. Neurology, 88, 1906–11.Google Scholar

Pan, Y, Meng, X, Jing, J, Li, H, Zhao, X, Liu, L, et al; CHANCE Investigators. (2017b). Association of multiple infarctions and ICAS with outcomes of minor stroke and TIA. Neurology, 88, 1081–8.Google Scholar

Pancioli, AM, Adeoye, O, Schmit, PA, Khoury, J, Levine, SR, Tomsick, TA,et al.; CLEAR-ER Investigators. (2013). Combined approach to lysis utilizing eptifibatide and recombinant tissue plasminogen activator in acute ischemic stroke-enhanced regimen stroke trial. Stroke, 44, 2381–7.Google Scholar

Rödén-Jüllig, Å, Britton, M, Malmkvist, K, Leijd, B. (2003). Aspirin in the prevention of progressing stroke: a randomized controlled study. J Intern Med, 254, 584–90.Google Scholar

Sandercock, PAG, Counsell, C, Tseng, MC, Cecconi, E. (2014). Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev, 3. CD000029. doi:10.1002/14651858.CD000029.pub3.Google Scholar

Siebler, M, Hennerici, MG, Schneider, D, von Reutern, GM, Seitz, RJ, Röther, J, et al. (2011). Safety of tirofiban in acute ischemic stroke: the SaTIS trial. Stroke, 42, 2388–92.Google Scholar

Thompson, DD, Murray, GD, Candelise, L, Chen, Z, Sandercock, PA, Whiteley, WN. (2015). Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials. Int J Stroke, 10, 1024–30.Google Scholar

Torgano, G, Zecca, B, Monzani, V, Maestroni, A, Rossi, P, Cazzaniga, M, et al. (2010). Effect of intravenous tirofiban and aspirin in reducing short-term and long-term neurologic deficit in patients with ischemic stroke: a double-blind randomized trial. Cerebrovasc Dis, 29, 275–81.Google Scholar

Wang, Y, Meng, X, Chen, W, Lin, Y, Pan, Y, Jing, J, et al.; PRiNCE Investigators. (2018). Ticagrelor with aspirin on platelet reactivity in acute non-disabling cerebrovascular events (PRINCE) trial – Final analysis. International Stroke Conference. https://professional.heart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_498791.pdf. Accessed August 2018.Google Scholar

Wang, Y, Wang, Y, Zhao, X, Liu, L, Wang, D, Wang, C, et al.; CHANCE Investigators. (2013). Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med, 369, 11–19.Google Scholar